This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jose A. Yaryura-Tobias, MD; Fugen A. Neziroglu, PhD
Institute for Bio-Behavioral Therapy and Research 935 Northern Blvd, Suite 102 Great Neck, NY 11021

Arch Gen Psychiatry. 1996;53(7):653-654.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In a contribution to the January 1995 issue of the Archives comparing the efficacy and tolerability of clomipramine, fluoxetine, fluvoxamine, and sertraline, Greist et al,₁ using a method of meta-analysis, found all 4 agents to be effective in the treatment of patients who have obsessive-compulsive disorder (OCD). Whereas all 4 are serotonin-transport inhibitors, clomipramine, with its noradrenergic transport—inhibition component, most notably showed an efficacy advantage. With regard to this finding, Greist et al stated, "It seems that something may be missing in fluoxetine, fluvoxamine, and sertraline that clomipramine contains." They posed the question, "Will agents such as... venlafaxine hydrochloride, which have selective and potent serotonin and noradrenergic transport inhibition and a better side-effect profile than clomipramine, work well in treating OCD?" I wish to respond by reporting our limited experience with venlafaxine therapy in such patients. Research that we have conducted suggests that the preliminary answer to this . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?